News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
123,345 Results
Type
Article (8809)
Company Profile (20)
Press Release (114516)
Section
Business (30084)
Career Advice (186)
Deals (3963)
Drug Delivery (17)
Drug Development (30802)
Employer Resources (23)
FDA (3770)
Job Trends (3438)
News (67733)
Policy (5890)
Tag
Academia (853)
Allergies (21)
Alliances (8439)
Alzheimer's disease (543)
Approvals (3766)
Artificial intelligence (21)
Bankruptcy (33)
Best Places to Work (3308)
Breast cancer (33)
Cancer (310)
Cardiovascular disease (35)
Career advice (166)
Cell therapy (47)
Clinical research (26742)
Collaboration (100)
COVID-19 (828)
C-suite (26)
Cystic fibrosis (46)
Data (419)
Diabetes (38)
Diagnostics (1077)
Earnings (9539)
Employer resources (23)
Events (15145)
Executive appointments (67)
FDA (3922)
Funding (107)
Gene therapy (47)
GLP-1 (119)
Government (967)
Healthcare (4299)
Infectious disease (854)
Inflammatory bowel disease (35)
IPO (2056)
Job creations (296)
Job search strategy (146)
Layoffs (54)
Legal (916)
Lung cancer (65)
Manufacturing (30)
Medical device (1756)
Medtech (1757)
Mergers & acquisitions (1935)
Metabolic disorders (96)
Neuroscience (659)
NextGen Class of 2024 (1361)
Non-profit (3028)
Northern California (379)
Obesity (55)
Opinion (45)
Parkinson's disease (44)
Patents (24)
Peanut (21)
People (9961)
Phase I (6031)
Phase II (11689)
Phase III (10621)
Pipeline (122)
Postmarket research (913)
Preclinical (1525)
Radiopharmaceuticals (39)
Rare diseases (89)
Real estate (613)
Regulatory (4406)
Research institute (781)
Resumes & cover letters (22)
Southern California (263)
Startups (692)
United States (2883)
Vaccines (148)
Weight loss (30)
Date
Last 7 days (162)
Last 30 days (775)
Last 365 days (8188)
2024 (7530)
2023 (9254)
2022 (10749)
2021 (12367)
2020 (12498)
2019 (10394)
2018 (7835)
2017 (6376)
2016 (6418)
2015 (7066)
2014 (4843)
2013 (3385)
2012 (3539)
2011 (3761)
2010 (2956)
Location
Africa (176)
Asia (7329)
Australia (1342)
California (739)
Canada (217)
China (63)
Colorado (29)
Connecticut (49)
Delaware (22)
Europe (17452)
Florida (97)
Georgia (38)
Illinois (67)
Indiana (83)
Japan (32)
Maryland (116)
Massachusetts (514)
Michigan (25)
Minnesota (33)
New Jersey (271)
New York (233)
North Carolina (115)
Northern California (379)
Ohio (28)
Pennsylvania (172)
South America (180)
Southern California (263)
Texas (98)
Washington State (74)
123,345 Results for "foundation fighting blindness".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Drug Development
Opus Genetics Announces $1.7 Million in Project-based Funding from the Foundation Fighting Blindness to Support Two Preclinical Programs
Opus Genetics, a patient-first, clinical-stage gene therapy company developing treatments for inherited retinal diseases, announced it has received $1.7 million in project-based funding from the Foundation Fighting Blindness to help advance two preclinical candidate programs.
June 13, 2024
·
3 min read
Press Releases
Foundation Fighting Blindness and Usher III Initiative Partner to Launch a Natural History Study for Usher Syndrome Type 3
August 14, 2024
·
3 min read
BioCapital
Foundation Fighting Blindness to Host PRPH2 and Associated Retinal Diseases Workshop
The Foundation Fighting Blindness will host the free in-person PRPH2 and Associated Retinal Diseases Workshop on March 29–31, 2023, at the Hilton La Jolla Torrey Pines in San Diego, CA.
January 25, 2023
·
4 min read
Business
Foundation Fighting Blindness Announces Leadership Changes
The Foundation Fighting Blindness announced today the promotions of Jason Menzo to chief executive officer (CEO) of the Foundation and Russell Kelley, PhD, MBA, to managing director of the Retinal Degeneration (RD) Fund, the venture arm of the Foundation, effective July 1, 2022.
June 21, 2022
·
6 min read
BioCapital
Verana Health Partners with Foundation Fighting Blindness to Integrate Genetic Testing Data into Real-World Evidence Research
Verana Health® announce a partnership focused on providing the life sciences community with deeper and broader data to optimize and expedite clinical trials.
November 2, 2023
·
5 min read
Genetown
Foundation Medicine Launches RNA Sequencing Test, FoundationOne®RNA, in the U.S.
Foundation Medicine, Inc., announced the U.S. launch of FoundationOne®RNA, a tissue-based RNA sequencing test for the detection of cancer-related fusions across 318 genes.
May 21, 2024
·
7 min read
BioCapital
Diana Davis Spencer Foundation Pledges $5M to Foundation Fighting Blindness for Inherited Retinal Disease Research
The Foundation Fighting Blindness, the world’s leading organization committed to finding treatments and cures for blinding retinal diseases, has announced the launch of the Diana Davis Spencer Foundation.
January 27, 2022
·
2 min read
Drug Development
INmune Bio, Inc. Completes Blinded Interim Analysis of Phase II Alzheimer’s Disease Trial
INmune Bio Inc. today confirmed the Phase II Alzheimer’s Disease clinical trial, AD02, is appropriately powered following a blinded sample size re-estimation using the trial’s primary endpoint, the Early Mild Alzheimer’s Cognitive Composite (EMACC).
June 27, 2024
·
7 min read
Press Releases
Bioxytran’s Medical Breakthrough in Fighting All Viruses
September 20, 2024
·
6 min read
Lone Star Bio
Texas Company’s Mission to Cure Macular Degeneration Blindness
Mesogen Inc. out of The Woodlands, Texas, has developed a transplantable Retinal Pigmented Epithelium patch to cure Macular Degeneration Blindness using autologous bone marrow-derived stem cells that carry no teratoma tumor risk and requires no immunosuppression.
April 30, 2024
·
1 min read
1 of 12,335
Next
